Filter by Year:
Press Releases
-
Mar 11, 2022
Foghorn Therapeutics to Participate at the 2022 Guggenheim Targeted Protein Degradation Day
-
Mar 10, 2022
Foghorn Therapeutics Provides Full Year 2021 Corporate Update and 2022 Outlook
-
Feb 28, 2022
Foghorn Therapeutics to Participate at the Cowen’s 42nd Annual Health Care Conference
-
Jan 10, 2022
Foghorn Therapeutics Announces Chief Scientific Officer Succession
-
Jan 07, 2022
Foghorn Therapeutics to Participate at the H.C. Wainwright BioConnect Conference
Displaying 21 - 25 of 25